Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers.
about
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryDual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.Study of interaction energies between the PAMAM dendrimer and nonsteroidal anti-inflammatory drug using a distributed computational strategy and experimental analysis by ESI-MS/MS.Multifunctional trackable dendritic scaffolds and delivery agents.Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.Past and future evolution in colloidal drug delivery systems.Cancer, chitosan nanoparticles and catalytic nucleic acids.Review: doxorubicin delivery systems based on chitosan for cancer therapy.Charge affects the oral toxicity of poly(amidoamine) dendrimers.Gold nanoparticle platforms as drug and biomacromolecule delivery systems.Recent advances in the field of nanometric drug carriers.Monolayer coated gold nanoparticles for delivery applicationsPharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs.Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.Nanoencapsulation for drug deliverySurface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Ligand exchange on gold nanoparticles for drug delivery and enhanced therapeutic index evaluated in acute myeloid leukemia models.A biophysical perspective of understanding nanoparticles at large.Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells.Synthesis of New Functionalized Citric Acid-based Dendrimers as Nanocarrier Agents for Drug Delivery.Anionic amphiphilic dendrimers as antibacterial agentsVortex-induced alignment of a water soluble supramolecular nanofiber composed of an amphiphilic dendrimer.Activation Effect of Fullerene C60 on the Carbon Dioxide Absorption Performance of Amine-Rich Polypropylenimine Dendrimers.Dual stimuli-responsive nano-vehicles for controlled drug delivery: mesoporous silica nanoparticles end-capped with natural chitosan.Monte-Carlo simulations of PAMAM dendrimer-DNA interactions.Multifunctional Nano/Micro Polymer Capsules as Potential Drug Delivery and Imaging AgentsMultifunctional Trackable Dendritic Scaffolds and Delivery AgentsNew serinolic amino-s-triazines by chemoselective amination of cyanuric chloride and their (pro)diastereomerism in restricted rotational phenomenaLight-Regulated Release of Entrapped Drugs from Photoresponsive Gold Nanoparticles
P2860
Q28085438-9A21C869-521E-4EAC-8897-8514C4822C58Q30362004-DBE3854D-D920-424F-ADA9-22E204B9EA78Q33740696-BA8B77BA-9368-41D2-AE60-7B15E2C51258Q34972145-F6873DF7-79B1-4023-8DBD-C47588814B04Q35808333-10B15975-A7C5-4257-83FC-1A57F37D2058Q36377061-D5DEF1E9-BB56-4A89-8C4D-D6B66A7EAD6BQ36823809-29DDCF6B-408D-4E39-9AD3-912A2721478AQ37039030-81C130CB-15EF-47E7-8671-D02B6340F101Q37363420-51A22299-4B59-4B74-9133-0003F6EE5C81Q37380142-DB748D4B-4013-4449-877B-C88134C0D126Q37386295-F2E7FE8E-123F-4292-81F4-79B141D77B60Q37765036-97A935B3-405E-4E24-BB73-71BE2ACCC630Q37855847-2FE1B16A-B2C4-43E8-AC09-CC37C995BF24Q37934050-0347B11C-C494-4CA7-AE70-F44DA847E734Q38179927-419C6825-2913-4C01-9751-15F8CAEC1A99Q38539866-F3944B66-75B5-4506-A123-11D51A09FE80Q38594967-43585BAE-DFE4-44B8-8090-4F997FE14FDCQ38899902-9B46DE91-244D-491F-B841-61DA5FEBB43CQ38989899-F12410A4-6235-4F16-95BD-3DF9EF387DBDQ39577758-58530833-3E40-48E4-92EF-B5A935B98A50Q39897176-DE5231A2-8977-44C2-AFA7-8AF9910AC9BEQ40553343-5CAD767D-7B26-4D6D-82D0-B95E66D1E3DDQ41816594-AE689867-0988-42F6-892C-B094D4E40F21Q44818991-5BB354C0-721C-499C-AC7B-42F5318EB34EQ51828654-80C005B2-DC3B-4A50-BF18-3C65A76D0F99Q53440698-448DA190-664B-4AD3-AFE1-5723A8ED4D1FQ53526838-3373E9BD-744F-4DB3-9971-AFE26981BD23Q57341109-FCA47058-FBF8-4F3E-9586-62F330ABB08CQ57517641-0173A836-E319-4351-BD78-23CE6244A4D8Q57597457-ACF98ACC-210B-4E17-B83E-251F2FFE72F6Q59127617-686C068A-DA7C-4085-80C8-31F11DDB55E1
P2860
Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@en
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@nl
type
label
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@en
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@nl
prefLabel
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@en
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@nl
P2860
P356
P1476
Dendrimers as drug delivery ve ...... ive compounds with dendrimers.
@en
P2093
Eric E Simanek
Hannah L Crampton
P2860
P304
P356
10.1002/PI.2230
P577
2007-03-01T00:00:00Z